China, Sept. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Prospective randomized controlled study on the effect of "gastric cavity negative pres... Read More
China, Sept. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Research on Ultrasound-Guided Nerve Block for Perioperative Organ Protection in Hip Su... Read More
China, Sept. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Development and Clinical Application of an Intelligent Echocardiography-Based Integrat... Read More
China, Sept. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Precise exercise intervention for patients with metabolic dysfunction-associated fatty... Read More
China, Sept. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Contralesional rTMS targets and frequencies in subacute stroke with severely impaired ... Read More
China, Sept. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy of Vunakizumab in Patients with Moderate-to-Severe Plaque Psoriasis and Obesi... Read More
China, Sept. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Prospective Randomized Controlled Trial of Lubiprostone as Adjuvant Combined with Mo... Read More
China, Sept. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Diagnostic Value of Non-Contrast Cranial CT in Differentiating Hemorrhagic Anterior Cr... Read More
China, Sept. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the value of eight molecular markers of platelet activation in the diagnosis ... Read More
China, Sept. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Determination of the ED50 and ED95 of Remimazolam Combined with Target-Controlled Infu... Read More